Literature DB >> 26774577

New approaches to treating pain.

Andrea Wolkerstorfer1, Norbert Handler1, Helmut Buschmann2.   

Abstract

Pain is the most common reason for patients seeking medical care resulting in an estimated world market for analgesics of more than USD 50 billion. Pain is a highly complex, heterogeneous and dynamic process characterized by specific patterns of phenotypic sensory neuronal change. Current treatment options for pain include opioids and non-opioid analgesics, acetaminophen and non-steroidal anti-inflammatory drugs and other drug classes such as antidepressants and anticonvulsants and a combination thereof. Novel approaches are focusing on the optimization of side-effect profiles of opioid based analgesics, the improvement of selectivity for specific opioid receptors, or by addressing molecular gateways implicated in pain. Promising candidates in development target various types of voltage-gated ion channels and receptors for capsaicin and analogs. Currently, after decades of pain research it has to be stated that the assessment, prevention and treatment of pain in industrialized countries as well as in low-income and middle-income countries are neither adequate nor equitable. Further research is needed so that specifically chronic pain control can be improved and individualized.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Analgesics; NSAIDs; Non-opioids; Opioids; Pain

Mesh:

Substances:

Year:  2015        PMID: 26774577     DOI: 10.1016/j.bmcl.2015.12.103

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

Review 1.  The dynamic interaction between pain and opioid misuse.

Authors:  Adrianne R Wilson-Poe; Jose A Morón
Journal:  Br J Pharmacol       Date:  2017-06-28       Impact factor: 8.739

2.  Morphine-induced hyperalgesia involves mu opioid receptors and the metabolite morphine-3-glucuronide.

Authors:  Laurie-Anne Roeckel; Valérie Utard; David Reiss; Jinane Mouheiche; Hervé Maurin; Anne Robé; Emilie Audouard; John N Wood; Yannick Goumon; Frédéric Simonin; Claire Gaveriaux-Ruff
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

3.  Therapeutic potential for leukocyte elastase in chronic pain states harboring a neuropathic component.

Authors:  Kiran Kumar Bali; Rohini Kuner
Journal:  Pain       Date:  2017-11       Impact factor: 7.926

4.  The Hypnotic, Anxiolytic, and Antinociceptive Profile of a Novel µ-Opioid Agonist.

Authors:  Guilherme Carneiro Montes; Bianca Nascimento Monteiro da Silva; Bismarck Rezende; Roberto Takashi Sudo; Vitor Francisco Ferreira; Fernando de Carvalho da Silva; Angelo da Cunha Pinto; Bárbara Vasconcellos da Silva; Gisele Zapata-Sudo
Journal:  Molecules       Date:  2017-05-16       Impact factor: 4.411

5.  An Investigation of the Molecular Mechanisms Underlying the Analgesic Effect of Jakyak-Gamcho Decoction: A Network Pharmacology Study.

Authors:  Ho-Sung Lee; In-Hee Lee; Kyungrae Kang; Sang-In Park; Tae-Wook Kwon; Dae-Yeon Lee
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-01       Impact factor: 2.629

6.  Effects of analgesics and antidepressants on TREK-2 and TRESK currents.

Authors:  Hyun Park; Eun-Jin Kim; Jaehee Han; Jongwoo Han; Dawon Kang
Journal:  Korean J Physiol Pharmacol       Date:  2016-06-23       Impact factor: 2.016

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.